SEC Form D · Amendment · filed September 14, 2017
Caelum Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Jeffrey Dachis · New York, NYDirectorMartin W. Goldman · New York, NYDirectorStuart Ellman · New York, NYExecKenneth W. Cappell · New Yor, NYDirectorWilliam W. Natbony · New York, NYDirectorSteve Traxler · Chicago, ILDirectorMichael Spector · New York, NYExec · DirectorJeffrey S. Paley · New York, NYDirectorJohn S. Struck · Hamilton, BermudaDirectorOlaf Carlson-Wee · Danville, CAExecEthan Kay · Irvine, CADirectorWilliam A. Krusen · Tampa, FLDirectorKathleen M. Shanahan · Tampa, FLDirectorAlbert G. Narvades · Tampa, FLExec · DirectorJames C. Smith · Tampa, FLDirectorNabiha Saklayen · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗